Evaluation of contact precautions for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus

Autor: Marcus J. Zervos, Katherine Reyes, George Alangaden, Jennifer J. Pietsch, Muhammad Yasser Alsafadi, Laura Johnson, Ana C. Bardossy, Patricia Starr, Eman Chami, Daniela Moreno
Rok vydání: 2017
Předmět:
Methicillin-Resistant Staphylococcus aureus
medicine.medical_specialty
Epidemiology
Bacteremia
030501 epidemiology
medicine.disease_cause
Staphylococcal infections
Vancomycin-Resistant Enterococci
Microbiology
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
Infection control
Vancomycin-resistant Enterococcus
030212 general & internal medicine
Retrospective Studies
Cross Infection
Infection Control
biology
business.industry
Health Policy
Public Health
Environmental and Occupational Health
Pneumonia
Ventilator-Associated
Staphylococcal Infections
biochemical phenomena
metabolism
and nutrition
bacterial infections and mycoses
medicine.disease
biology.organism_classification
Methicillin-resistant Staphylococcus aureus
Discontinuation
Infectious Diseases
Enterococcus
Staphylococcus aureus
Population Surveillance
0305 other medical science
business
Zdroj: American Journal of Infection Control. 45:1369-1371
ISSN: 0196-6553
DOI: 10.1016/j.ajic.2017.06.017
Popis: Background There are limited controlled data demonstrating contact precautions (CPs) prevent methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) infections in endemic settings. We evaluated changes in hospital-acquired MRSA and VRE infections after discontinuing CPs for these organisms. Methods This is a retrospective study done at an 800-bed teaching hospital in urban Detroit. CPs for MRSA and VRE were discontinued hospital-wide in 2013. Data on MRSA and VRE catheter-associated urinary tract infections (CAUTIs), ventilator-associated pneumonia (VAP), central line–associated bloodstream infections (CLABSIs), surgical site infections (SSIs), and hospital-acquired MRSA bacteremia (HA-MRSAB) rates were compared before and after CPs discontinuation. Results There were 36,907 and 40,439 patients hospitalized during the two 12-month periods: CPs and no CPs. Infection rates in the CPs and no-CPs periods were as follows: (1) MRSA infections: VAP, 0.13 versus 0.11 ( P = .84); CLABSI, 0.11 versus 0.19 ( P = .45); SSI, 0 versus 0.14 ( P = .50); and CAUTI, 0.025 versus 0.033 ( P = .84); (2) VRE infections: CAUTI, 0.27 versus 0.13 ( P = .19) and CLABSI, 0.29 versus 0.3 ( P = .94); and (3) HA-MRSAB rates: 0.14 versus 0.11 ( P = .55), respectively. Conclusions Discontinuation of CPs did not adversely impact endemic MRSA and VRE infection rates.
Databáze: OpenAIRE
Externí odkaz: